Company Profiles

driven by the PitchBook Platform

Avexxin

Description

Developer of small molecule therapeutics designed to treat chronic inflammatory diseases. The company's small molecule therapeutics address inflammatory disorders and cancers that are not adequately treated with existing therapies, enabling patients to improve the quality of their lives.

2005

Founded

PRIVATE

Status

Series B

Latest Deal Type

$1.8M

Latest Deal Amount

$7.06M

Total Amount Raised

7

Investors

Description

Developer of small molecule therapeutics designed to treat chronic inflammatory diseases. The company's small molecule therapeutics address inflammatory disorders and cancers that are not adequately treated with existing therapies, enabling patients to improve the quality of their lives.

Website:

www.avexxin.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

Department of Biology, Norwegian University of Science and Technology Høgskoleringen 5 7491 TrondheimNorway +47 73 59 61 07
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avexxin's full profile, request a free trial.

Avexxin Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avexxin Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Karolinska InnovationsOtherMinority000 0000000 0000
Leiv Eiriksson InvestOtherMinority000 0000000 0000
Leiv Eriksson NyskapingAccelerator/IncubatorMinority000 0000000 0000
Norwegian Research CouncilOther000 0000000 0000
SarsiaVenture CapitalMinority000 0000000 0000
Karolinska Innovations Other
Leiv Eiriksson Invest Other
Leiv Eriksson Nyskaping Accelerator/Incubator
Norwegian Research Council Other
Sarsia Venture Capital

Avexxin Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Mikael ØrumCo-Founder, Chief Executive Officer, Chairman & President
Henrik StageChief Financial Officer
Berit Johansen Ph.DCo-Founder, Chief Scientific Officer & Board Member
Scott WoodwardChief Business Officer
Peter Damsbo MDChief Medical Officer
Mikael Ørum Co-Founder, Chief Executive Officer, Chairman & President
Henrik Stage Chief Financial Officer
Berit Johansen Ph.D Co-Founder, Chief Scientific Officer & Board Member
Scott Woodward Chief Business Officer
Peter Damsbo MD Chief Medical Officer

Avexxin Board Members (6)

NameRepresentingRoleSinceContact
Info
Berit Johansen Ph.DAvexxinCo-Founder, Chief Scientific Officer & Board Member000 0000
Bo Anders LjungqvistSelfBoard Member000 0000
Erlend SkagsethSarsiaPartner, BioLife Sciences & Financial Control000 0000
Farzad Abdi-DezfuliSarsiaPartner Investment Advisor000 0000
Jan FossLeiv Eriksson NyskapingSenior Advisor & Investment Manager000 0000
Berit Johansen Ph.D Co-Founder, Chief Scientific Officer & Board Member Avexxin
Bo Anders Ljungqvist Board Member Self
Erlend Skagseth Partner, BioLife Sciences & Financial Control Sarsia
Farzad Abdi-Dezfuli Partner Investment Advisor Sarsia
Jan Foss Senior Advisor & Investment Manager Leiv Eriksson Nyskaping
Request full access to PitchBook